Article
Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer’s disease
31 Mar 2021
Abstract excerpt
We evaluated the utility of leucocyte epigenomic-biomarkers for Alzheimer's Disease (AD) detection and elucidates its molecular pathogeneses. Genome-wide DNA methylation analysis was performed using the Infinium MethylationEPIC BeadChip array in 24 late-onset AD (LOAD) and 24 cognitively healthy subjects. Data were analyzed using six Artificial Intelligence (AI) methodologies including Deep Learning (DL) followed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
